PODD: Partnerships in Drug Delivery Agenda 2025 Page 2

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

3:35PM - 4:05PM

Enabling At-Home Delivery of Vaccines

Moderated by:

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Panelists:

Derek O’Hagan, PhD, Global Head of Discovery Support and New Technologies, GSK Vaccines

Duncan Paterson, CEng, MBA, Senior Director, Device Development, AstraZeneca

4:05PM - 4:35PM

New Progress in Ophthalmic Delivery

Moderated by:

Shankar Swaminathan, PhD, Team Lead, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Panelists:

Tim Carroll, MS, MBA, Delivery Strategy & Surgeon Engagement, Genentech

4:35PM - 5:05PM

Respiratory Devices and Inhaled Biologics

Combination Devices

3:35PM - 4:05PM

Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success

Moderated by:

Kinsuk Shah, M.Sc and MBA, SR AD, Combination Product Steward, Boehringer Ingelheim

Panelists:

Saran Baskaran, BSE, MEng, Associate Director, R&D Combination Products, AstraZeneca

4:05PM - 4:35PM

Ensuring Sustainability Throughout Drug and Device Development

Moderated by:

Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals

4:35PM - 5:05PM

Utilizing AI to Facilitate Combination Product Development

Moderated by:

Manfred Maeder, PhD, VP Global Device & Packaging Development in TRD, Novartis

Novel Drug Delivery and Device Technologies

3:35PM - 4:05PM

Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain

Panelists:

Prasad Peri, AVP Regulatory Affairs Connected Delivery, Devices, and Digital Health, Eli Lilly and Company

4:05PM - 4:35PM

Challenges and Opportunities in Delivering Hyperconcentrated Formulations

Moderated by:

Stephanie Reed, PhD, Director, Early Stage Formulation, Biopharmaceutical Development, AstraZeneca

Panelists:

Deep Bhattacharya, PhD, Senior Scientist Formulation and Process Development- Biotherapeutics, Pfizer

Mark DeStefano, Associate Director, Combination Devices and Devices R&D, Teva Pharmaceuticals

Ryan Doxey, Director, Technical Services, Kymanox

4:35PM - 5:05PM

Novel Approaches to Delivery Large Volume Therapies

Moderator:

Ravi Kaushik, Vice President, Global Head of Device & Digital Innovation & Product Strategy, PDT, Takeda

Showing Events in 1 Track from 05:05pm to 05:10pm

PODD Conference Concludes

5:05PM - 5:10PM

PODD Conference Concludes

Showing Events in 1 Track from 08:10am to 08:20am

Co-Chairs’ Opening Remarks

8:10AM - 8:20AM

Co-Chairs’ Opening Remarks

Speakers:

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Showing Events in 1 Track from 08:20am to 09:10am

Morning General Session

8:20AM - 8:50AM

Payer Perspectives on Drug Delivery

Moderated by:

Mark Simon, MBA, Strategic Advisor, Sun Pharmaceuticals Industries, Ltd.

Panelists:

Michael Sherman, MD, MBA, MS, CEO, Advisor, RA Capital Management, Sherman Healthcare Solutions

Lambert van der Walde, MBA, SVP & Executive Director, Center for Health Care Research, UnitedHealth Group

8:50AM - 9:10AM

Drug Delivery Pipeline & Technologies, a Year in Review

Speaker:

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:10am to 09:35am

Patient Keynote

9:10AM - 9:35AM

Patient Keynote: How a CRISPR-Based Therapy Changed Jimi Olaghere’s Life with SCD

Speaker:

Jimi Olaghere, Patient Advocate, Lived-Experience Expert

Showing Events in 1 Track from 09:35am to 10:45am

PODD Networking Break & Partnering

9:35AM - 10:45AM

PODD Networking Break & Partnering

Showing Events in 1 Track from 10:45am to 11:45am

Morning General Session Continued

10:45AM - 11:25AM

Zeitgeist Presentation: Endogenous Targeted Delivery Strategies to Advance Nucleic Acid Therapeutics

Speaker:

Mansoor Amiji, PhD, University Distinguished Professor, Northeastern University

11:25AM - 11:45AM

Dealmaking Fireside Discussion: Bringing Drug Delivery to the Front

Speaker:

Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company

Showing Events in 1 Track from 11:45am to 12:00pm

Reserved Session

11:45AM - 12:00PM

Reserved Session

Showing Events in 1 Track from 12:00pm to 12:40pm

PODD Annual Soapbox Presentations

12:00PM - 12:40PM

PODD Annual Soapbox Presentations, Hosted by Pfizer

Moderated by:

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Showing Events in 1 Track from 12:40pm to 01:55pm

Luncheon & Partnering Meetings

12:40PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 1 Track from 01:55pm to 05:05pm

Afternoon Track Choices

1:55PM - 5:05PM

Afternoon Track Choices

Showing Events in 4 Tracks from 02:00pm to 03:15pm

Novel Formulations

Chaired by:

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

2:00PM - 2:30PM

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

Moderated by:

Vinu Krishnan, PhD, Principal Research Scientist, CMC Formulation Development & Drug Delivery, AbbVie

Panelists:

Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

2:30PM - 2:45PM

Reserved Session

2:45PM - 3:15PM

Novel Approaches to Achieve Precision Tissue Targeting for Nucleic Acid Therapeutics

Moderated by:

Drew Applefield, PhD, Director of Search & Evaluation, Platform Technologies, Sanofi

Panelists:

Ketaki Deshmukh, PhD, Sr. Scientist, Non Viral Delivery, Novo Nordisk

Subhadeep Dutta, Formulation Scientist, Merck Research Laboratories

Manmohan Singh, PhD, Senior Vice President, Head, Pharmaceutical Sciences and Delivery Technologies, Beam Therapeutics

Novel Delivery Modalities

Chaired by:

Lipa Shah, PhD, Director Science and Technology, Drug Development/Pharmaceutical Development, Novartis

2:00PM - 2:30PM

Physical and Formulation Approaches for Brain Delivery

Panelists:

Hicham Majd, PhD, Global Device and Packaging Innovation Lead, Novartis

2:30PM - 2:45PM

Reserved Session

2:45PM - 3:15PM

New Approaches for Expanding Transdermal Delivery Opportunities

Panelists:

Rikhav Gala, PhD, Group Lead, Senior Principal Scientist, Pfizer

Combination Devices

2:00PM - 2:30PM

Platform Approaches to Streamline Combination Product Development

Moderated by:

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Panelists:

Bradley Gould, MEng, Associate Director, Device and Combination Product Development, AbbVie

Shirish Ingawale, PhD, Director, Device and Combination Product Development, Takeda

2:30PM - 2:45PM

Reserved Session

2:45PM - 3:15PM

Establishing a Regulatory Framework for Global Combination Device Development

Moderated by:

E Guan, PhD, Head of Injection Systems, Takeda

Novel Drug Delivery and Device Technologies

Chaired by:

Roger Liu, MEng, MBA, Director, Combination Product Development, AbbVie

2:00PM - 2:30PM

The Shift from IV to SC Delivery: Patient and Provider Perspectives

Moderated by:

Charles Theuer, MD, PhD, Chief Medical Officer, Halozyme

2:30PM - 2:45PM

Reserved Session

2:45PM - 3:15PM

Advances and Opportunities in Dual Chamber Injectables

Showing Events in 1 Track from 03:15pm to 03:30pm

15-Minute Break

3:15PM - 3:30PM

15-Minute Break

Showing Events in 4 Tracks from 03:35pm to 05:05pm

Novel Formulations

Chaired by:

Ana Gomes dos Santos, PhD, Director of Pharm Sci External Evaluations, AstraZeneca

3:35PM - 4:05PM

Advances in Payload Delivery and Drug Conjugation

Moderated by:

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis

Panelists:

Stefan Yohe, PhD, Associate Research Fellow, Pfizer

4:05PM - 4:35PM

Drug Delivery in the Golden Age of Peptides and Biologics: Novel Formulation Approaches for Oral Delivery

Moderated by:

Sarah Tao, PhD, Head of Search and Evaluation, Technology Platforms, Sanofi

4:35PM - 5:05PM

Accomplishing Sustained Release and Long Acting Delivery

Panelists:

Seth Forster, PhD, Associate Principal Scientist, Merck Research Laboratories

Shrenik Mehta, PhD, Senior Principal Scientist, Pharmaceutical Development – Drug Delivery, Genentech

Puneet Tyagi, PhD, Associate Director, AstraZeneca

Novel Delivery Modalities

Chaired by:

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

3:35PM - 4:05PM

Enabling At-Home Delivery of Vaccines

Moderated by:

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Panelists:

Derek O’Hagan, PhD, Global Head of Discovery Support and New Technologies, GSK Vaccines

Duncan Paterson, CEng, MBA, Senior Director, Device Development, AstraZeneca

4:05PM - 4:35PM

New Progress in Ophthalmic Delivery

Moderated by:

Shankar Swaminathan, PhD, Team Lead, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Panelists: